カテゴリー： QYResearch, 世界, 医療/バイオ

メトトレキサート錠のグローバル市場2023年：2mg、2.5mg、10mg、その他

◆英語タイトル：Global Methotrexate Tablets Market Research Report 2023

QYResearchが発行した調査報告書（QYR23MA8816）◆商品コード：QYR23MA8816
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2023年3月
◆ページ数：105
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界のメトトレキサート錠市場について調査・分析し、世界のメトトレキサート錠市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（2mg、2.5mg、10mg、その他）、用途別セグメント分析（がん、関節リウマチ、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Accord Healthcare、Cipla、Morningside Healthcare、Ebewe Pharma、Orion、Nihon Generic、Nippon Zoki Pharmaceutical、Daito Pharmaceutical、Nichi-Iko Pharmaceutical、Towa Pharmaceutical、Mitsubishi Tanabe Pharma、Ayumi Pharmaceutical、Sinomune Pharmaceutical、Maoxiang Pharmacy、INE、Zhengqing Pharmaceuticalなどが含まれています。世界のメトトレキサート錠市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、メトトレキサート錠市場規模を推定する際に考慮しました。

・メトトレキサート錠市場の概要
- 製品の定義
- メトトレキサート錠のタイプ別セグメント
- 世界のメトトレキサート錠市場規模：タイプ別分析（2mg、2.5mg、10mg、その他）
- メトトレキサート錠の用途別セグメント
- 世界のメトトレキサート錠市場規模：用途別分析（がん、関節リウマチ、その他）
- 世界のメトトレキサート錠市場規模予測（2018年-2029年）
- メトトレキサート錠の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- メトトレキサート錠市場の競争状況およびトレンド

・メトトレキサート錠の地域別市場規模
- 北米のメトトレキサート錠市場規模（2018年-2029年）
- アメリカのメトトレキサート錠市場規模（2018年-2029年）
- ヨーロッパのメトトレキサート錠市場規模（2018年-2029年）
- アジア太平洋のメトトレキサート錠市場規模（2018年-2029年）
- 中国のメトトレキサート錠市場規模（2018年-2029年）
- 日本のメトトレキサート錠市場規模（2018年-2029年）
- 韓国のメトトレキサート錠市場規模（2018年-2029年）
- インドのメトトレキサート錠市場規模（2018年-2029年）
- オーストラリアのメトトレキサート錠市場規模（2018年-2029年）
- 中南米のメトトレキサート錠市場規模（2018年-2029年）
- 中東・アフリカのメトトレキサート錠市場規模（2018年-2029年）

・タイプ別セグメント：2mg、2.5mg、10mg、その他
- 世界のメトトレキサート錠のタイプ別販売量（2018年-2023年）
- 世界のメトトレキサート錠のタイプ別売上（2018年-2023年）
- 世界のメトトレキサート錠のタイプ別価格

・用途別セグメント：がん、関節リウマチ、その他
- 世界のメトトレキサート錠の用途別販売量（2018年-2023年）
- 世界のメトトレキサート錠の用途別売上（2018年-2023年）
- 世界のメトトレキサート錠の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Accord Healthcare、Cipla、Morningside Healthcare、Ebewe Pharma、Orion、Nihon Generic、Nippon Zoki Pharmaceutical、Daito Pharmaceutical、Nichi-Iko Pharmaceutical、Towa Pharmaceutical、Mitsubishi Tanabe Pharma、Ayumi Pharmaceutical、Sinomune Pharmaceutical、Maoxiang Pharmacy、INE、Zhengqing Pharmaceutical

・産業チェーンと販売チャネルの分析
- メトトレキサート錠産業チェーン分析
- メトトレキサート錠の主要原材料
- メトトレキサート錠の販売チャネル
- メトトレキサート錠のディストリビューター
- メトトレキサート錠の主要顧客

・メトトレキサート錠市場ダイナミクス
- メトトレキサート錠の業界動向
- メトトレキサート錠市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

Highlights
The global Methotrexate Tablets market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Methotrexate Tablets is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Methotrexate Tablets is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Methotrexate Tablets include Accord Healthcare, Cipla, Morningside Healthcare, Ebewe Pharma, Orion, Nihon Generic, Nippon Zoki Pharmaceutical, Daito Pharmaceutical and Nichi-Iko Pharmaceutical, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Methotrexate Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Methotrexate Tablets.
The Methotrexate Tablets market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Methotrexate Tablets market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Methotrexate Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Accord Healthcare
Cipla
Morningside Healthcare
Ebewe Pharma
Orion
Nihon Generic
Nippon Zoki Pharmaceutical
Daito Pharmaceutical
Nichi-Iko Pharmaceutical
Towa Pharmaceutical
Mitsubishi Tanabe Pharma
Ayumi Pharmaceutical
Sinomune Pharmaceutical
Maoxiang Pharmacy
INE
Zhengqing Pharmaceutical
Segment by Type
2mg
2.5mg
10mg
Others
Segment by Application
Cancers
Rheumatoid Arthritis
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Methotrexate Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Methotrexate Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Methotrexate Tablets Market Overview
1.1 Product Overview and Scope of Methotrexate Tablets
1.2 Methotrexate Tablets Segment by Type
1.2.1 Global Methotrexate Tablets Market Value Comparison by Type (2023-2029)
1.2.2 2mg
1.2.3 2.5mg
1.2.4 10mg
1.2.5 Others
1.3 Methotrexate Tablets Segment by Application
1.3.1 Global Methotrexate Tablets Market Value by Application: (2023-2029)
1.3.2 Cancers
1.3.3 Rheumatoid Arthritis
1.3.4 Others
1.4 Global Methotrexate Tablets Market Size Estimates and Forecasts
1.4.1 Global Methotrexate Tablets Revenue 2018-2029
1.4.2 Global Methotrexate Tablets Sales 2018-2029
1.4.3 Global Methotrexate Tablets Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Methotrexate Tablets Market Competition by Manufacturers
2.1 Global Methotrexate Tablets Sales Market Share by Manufacturers (2018-2023)
2.2 Global Methotrexate Tablets Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Methotrexate Tablets Average Price by Manufacturers (2018-2023)
2.4 Global Methotrexate Tablets Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Methotrexate Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Methotrexate Tablets, Product Type & Application
2.7 Methotrexate Tablets Market Competitive Situation and Trends
2.7.1 Methotrexate Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Methotrexate Tablets Players Market Share by Revenue
2.7.3 Global Methotrexate Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Methotrexate Tablets Retrospective Market Scenario by Region
3.1 Global Methotrexate Tablets Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Methotrexate Tablets Global Methotrexate Tablets Sales by Region: 2018-2029
3.2.1 Global Methotrexate Tablets Sales by Region: 2018-2023
3.2.2 Global Methotrexate Tablets Sales by Region: 2024-2029
3.3 Global Methotrexate Tablets Global Methotrexate Tablets Revenue by Region: 2018-2029
3.3.1 Global Methotrexate Tablets Revenue by Region: 2018-2023
3.3.2 Global Methotrexate Tablets Revenue by Region: 2024-2029
3.4 North America Methotrexate Tablets Market Facts & Figures by Country
3.4.1 North America Methotrexate Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Methotrexate Tablets Sales by Country (2018-2029)
3.4.3 North America Methotrexate Tablets Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Methotrexate Tablets Market Facts & Figures by Country
3.5.1 Europe Methotrexate Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Methotrexate Tablets Sales by Country (2018-2029)
3.5.3 Europe Methotrexate Tablets Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Methotrexate Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Methotrexate Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Methotrexate Tablets Sales by Country (2018-2029)
3.6.3 Asia Pacific Methotrexate Tablets Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Methotrexate Tablets Market Facts & Figures by Country
3.7.1 Latin America Methotrexate Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Methotrexate Tablets Sales by Country (2018-2029)
3.7.3 Latin America Methotrexate Tablets Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Methotrexate Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Methotrexate Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Methotrexate Tablets Sales by Country (2018-2029)
3.8.3 Middle East and Africa Methotrexate Tablets Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Methotrexate Tablets Sales by Type (2018-2029)
4.1.1 Global Methotrexate Tablets Sales by Type (2018-2023)
4.1.2 Global Methotrexate Tablets Sales by Type (2024-2029)
4.1.3 Global Methotrexate Tablets Sales Market Share by Type (2018-2029)
4.2 Global Methotrexate Tablets Revenue by Type (2018-2029)
4.2.1 Global Methotrexate Tablets Revenue by Type (2018-2023)
4.2.2 Global Methotrexate Tablets Revenue by Type (2024-2029)
4.2.3 Global Methotrexate Tablets Revenue Market Share by Type (2018-2029)
4.3 Global Methotrexate Tablets Price by Type (2018-2029)
5 Segment by Application
5.1 Global Methotrexate Tablets Sales by Application (2018-2029)
5.1.1 Global Methotrexate Tablets Sales by Application (2018-2023)
5.1.2 Global Methotrexate Tablets Sales by Application (2024-2029)
5.1.3 Global Methotrexate Tablets Sales Market Share by Application (2018-2029)
5.2 Global Methotrexate Tablets Revenue by Application (2018-2029)
5.2.1 Global Methotrexate Tablets Revenue by Application (2018-2023)
5.2.2 Global Methotrexate Tablets Revenue by Application (2024-2029)
5.2.3 Global Methotrexate Tablets Revenue Market Share by Application (2018-2029)
5.3 Global Methotrexate Tablets Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Accord Healthcare
6.1.1 Accord Healthcare Corporation Information
6.1.2 Accord Healthcare Description and Business Overview
6.1.3 Accord Healthcare Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Accord Healthcare Methotrexate Tablets Product Portfolio
6.1.5 Accord Healthcare Recent Developments/Updates
6.2 Cipla
6.2.1 Cipla Corporation Information
6.2.2 Cipla Description and Business Overview
6.2.3 Cipla Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Cipla Methotrexate Tablets Product Portfolio
6.2.5 Cipla Recent Developments/Updates
6.3 Morningside Healthcare
6.3.1 Morningside Healthcare Corporation Information
6.3.2 Morningside Healthcare Description and Business Overview
6.3.3 Morningside Healthcare Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Morningside Healthcare Methotrexate Tablets Product Portfolio
6.3.5 Morningside Healthcare Recent Developments/Updates
6.4 Ebewe Pharma
6.4.1 Ebewe Pharma Corporation Information
6.4.2 Ebewe Pharma Description and Business Overview
6.4.3 Ebewe Pharma Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ebewe Pharma Methotrexate Tablets Product Portfolio
6.4.5 Ebewe Pharma Recent Developments/Updates
6.5 Orion
6.5.1 Orion Corporation Information
6.5.2 Orion Description and Business Overview
6.5.3 Orion Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Orion Methotrexate Tablets Product Portfolio
6.5.5 Orion Recent Developments/Updates
6.6 Nihon Generic
6.6.1 Nihon Generic Corporation Information
6.6.2 Nihon Generic Description and Business Overview
6.6.3 Nihon Generic Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Nihon Generic Methotrexate Tablets Product Portfolio
6.6.5 Nihon Generic Recent Developments/Updates
6.7 Nippon Zoki Pharmaceutical
6.6.1 Nippon Zoki Pharmaceutical Corporation Information
6.6.2 Nippon Zoki Pharmaceutical Description and Business Overview
6.6.3 Nippon Zoki Pharmaceutical Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Nippon Zoki Pharmaceutical Methotrexate Tablets Product Portfolio
6.7.5 Nippon Zoki Pharmaceutical Recent Developments/Updates
6.8 Daito Pharmaceutical
6.8.1 Daito Pharmaceutical Corporation Information
6.8.2 Daito Pharmaceutical Description and Business Overview
6.8.3 Daito Pharmaceutical Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Daito Pharmaceutical Methotrexate Tablets Product Portfolio
6.8.5 Daito Pharmaceutical Recent Developments/Updates
6.9 Nichi-Iko Pharmaceutical
6.9.1 Nichi-Iko Pharmaceutical Corporation Information
6.9.2 Nichi-Iko Pharmaceutical Description and Business Overview
6.9.3 Nichi-Iko Pharmaceutical Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Nichi-Iko Pharmaceutical Methotrexate Tablets Product Portfolio
6.9.5 Nichi-Iko Pharmaceutical Recent Developments/Updates
6.10 Towa Pharmaceutical
6.10.1 Towa Pharmaceutical Corporation Information
6.10.2 Towa Pharmaceutical Description and Business Overview
6.10.3 Towa Pharmaceutical Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Towa Pharmaceutical Methotrexate Tablets Product Portfolio
6.10.5 Towa Pharmaceutical Recent Developments/Updates
6.11 Mitsubishi Tanabe Pharma
6.11.1 Mitsubishi Tanabe Pharma Corporation Information
6.11.2 Mitsubishi Tanabe Pharma Methotrexate Tablets Description and Business Overview
6.11.3 Mitsubishi Tanabe Pharma Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Mitsubishi Tanabe Pharma Methotrexate Tablets Product Portfolio
6.11.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.12 Ayumi Pharmaceutical
6.12.1 Ayumi Pharmaceutical Corporation Information
6.12.2 Ayumi Pharmaceutical Methotrexate Tablets Description and Business Overview
6.12.3 Ayumi Pharmaceutical Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Ayumi Pharmaceutical Methotrexate Tablets Product Portfolio
6.12.5 Ayumi Pharmaceutical Recent Developments/Updates
6.13 Sinomune Pharmaceutical
6.13.1 Sinomune Pharmaceutical Corporation Information
6.13.2 Sinomune Pharmaceutical Methotrexate Tablets Description and Business Overview
6.13.3 Sinomune Pharmaceutical Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Sinomune Pharmaceutical Methotrexate Tablets Product Portfolio
6.13.5 Sinomune Pharmaceutical Recent Developments/Updates
6.14 Maoxiang Pharmacy
6.14.1 Maoxiang Pharmacy Corporation Information
6.14.2 Maoxiang Pharmacy Methotrexate Tablets Description and Business Overview
6.14.3 Maoxiang Pharmacy Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Maoxiang Pharmacy Methotrexate Tablets Product Portfolio
6.14.5 Maoxiang Pharmacy Recent Developments/Updates
6.15 INE
6.15.1 INE Corporation Information
6.15.2 INE Methotrexate Tablets Description and Business Overview
6.15.3 INE Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.15.4 INE Methotrexate Tablets Product Portfolio
6.15.5 INE Recent Developments/Updates
6.16 Zhengqing Pharmaceutical
6.16.1 Zhengqing Pharmaceutical Corporation Information
6.16.2 Zhengqing Pharmaceutical Methotrexate Tablets Description and Business Overview
6.16.3 Zhengqing Pharmaceutical Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Zhengqing Pharmaceutical Methotrexate Tablets Product Portfolio
6.16.5 Zhengqing Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Methotrexate Tablets Industry Chain Analysis
7.2 Methotrexate Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Methotrexate Tablets Production Mode & Process
7.4 Methotrexate Tablets Sales and Marketing
7.4.1 Methotrexate Tablets Sales Channels
7.4.2 Methotrexate Tablets Distributors
7.5 Methotrexate Tablets Customers
8 Methotrexate Tablets Market Dynamics
8.1 Methotrexate Tablets Industry Trends
8.2 Methotrexate Tablets Market Drivers
8.3 Methotrexate Tablets Market Challenges
8.4 Methotrexate Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ メトトレキサート錠のグローバル市場2023年：2mg、2.5mg、10mg、その他(Global Methotrexate Tablets Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ボルチオキセチン臭化水素酸塩錠のグローバル市場2023年：5mg、10mg、20mg

    • ◆H&Iグローバルリサーチのお客様（例）◆